QIAGEN NV (QGEN)
37.19
+0.17
(+0.46%)
USD |
NYSE |
Jun 11, 13:32
QIAGEN Enterprise Value : 8.636B for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 8.636B |
| June 09, 2026 | 8.786B |
| June 08, 2026 | 8.473B |
| June 05, 2026 | 8.566B |
| June 04, 2026 | 8.747B |
| June 03, 2026 | 8.518B |
| June 02, 2026 | 8.361B |
| June 01, 2026 | 8.462B |
| May 29, 2026 | 8.547B |
| May 28, 2026 | 8.557B |
| May 27, 2026 | 8.443B |
| May 26, 2026 | 8.321B |
| May 22, 2026 | 8.245B |
| May 21, 2026 | 8.188B |
| May 20, 2026 | 8.229B |
| May 19, 2026 | 8.054B |
| May 18, 2026 | 7.959B |
| May 15, 2026 | 7.794B |
| May 14, 2026 | 7.858B |
| May 13, 2026 | 7.736B |
| May 12, 2026 | 7.942B |
| May 11, 2026 | 7.722B |
| May 08, 2026 | 7.806B |
| May 07, 2026 | 7.903B |
| May 06, 2026 | 8.095B |
| Date | Value |
|---|---|
| May 05, 2026 | 8.004B |
| May 04, 2026 | 7.996B |
| May 01, 2026 | 8.056B |
| April 30, 2026 | 8.124B |
| April 29, 2026 | 7.924B |
| April 28, 2026 | 8.008B |
| April 27, 2026 | 8.847B |
| April 24, 2026 | 8.913B |
| April 23, 2026 | 8.822B |
| April 22, 2026 | 9.234B |
| April 21, 2026 | 9.261B |
| April 20, 2026 | 9.454B |
| April 17, 2026 | 9.496B |
| April 16, 2026 | 9.438B |
| April 15, 2026 | 9.578B |
| April 14, 2026 | 9.603B |
| April 13, 2026 | 9.634B |
| April 10, 2026 | 9.424B |
| April 09, 2026 | 9.448B |
| April 08, 2026 | 9.502B |
| April 07, 2026 | 9.267B |
| April 06, 2026 | 9.401B |
| April 02, 2026 | 9.452B |
| April 01, 2026 | 9.319B |
| March 31, 2026 | 9.248B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 219.17B |
| Illumina, Inc. | 26.08B |
| Agilent Technologies, Inc. | 38.69B |
| Bruker Corp. | 9.952B |
| Bio-Rad Laboratories, Inc. | 7.619B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 68.04M |
| Revenue (Quarterly) | 492.32M |
| Total Expenses (Quarterly) | 424.28M |
| EPS Diluted (Quarterly) | 0.3257 |
| Gross Profit Margin (Quarterly) | 62.53% |
| Profit Margin (Quarterly) | 13.82% |
| Earnings Yield | 5.20% |
| Operating Earnings Yield | 6.63% |
| Normalized Earnings Yield | 5.924 |